Clinical Trials Directory

Trials / Terminated

TerminatedNCT04001179

Exploratory Metabolomics Study of Exhaled Breath in Pulmonary Embolism

Status
Terminated
Phase
Study type
Observational
Enrollment
1 (actual)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Pulmonary embolism is a frequent and recurrent pathology, especially in the elderly. It is often preventable, with high mortality and morbidity, making it a major public health issue. The clinical presentation of pulmonary embolism is non-specific and very highly variable, ranging from asymptomatic thrombus diagnosed incidentally to sudden death. The current diagnosis of pulmonary embolism is based on several diagnostic techniques, mainly non-invasive, which should be used sequentially. We propose to sample the volatile organic compounds using a device that allows them to be trapped on polymer cartridges. Sampling will be performed under monitoring of respiratory pressure and a capnograph to collect alveolar and upper respiratory tract air separately without contamination of the oral cavity or sinuses. This exploratory metabolic analysis will be non-targeted (analysis of all molecules detectable without a priori). The main objective of the study is to identify specific metabolic profiles to predict the results of ventilation-perfusion pulmonary tomoscintigraphy in subjects undergoing this examination for suspected acute pulmonary embolism. Secondary purposes : * To identify metabolic profiles to be used to predict, in combination with clinical probability scores, the results of ventilation-perfusion pulmonary tomoscintigraphy in subjects undergoing this examination for suspected acute pulmonary embolism.; * To correlate metabolic profiles with the topography of embolized lung territories

Conditions

Interventions

TypeNameDescription
OTHERPulmonary embolism diagnosis by nuclear medicine imagingnuclear medicine imaging

Timeline

Start date
2021-12-01
Primary completion
2021-12-01
Completion
2024-01-15
First posted
2019-06-27
Last updated
2024-08-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04001179. Inclusion in this directory is not an endorsement.